Breaking News Instant updates and real-time market news.

WBC

Wabco

$150.14

0.95 (0.64%)

07:17
09/25/17
09/25
07:17
09/25/17
07:17

Wabco price target raised to $166 from $145 at RBC Capital

RBC Capital analyst Seth Weber raised his price target on Wabco as he is upbeat about the company's recent deals. He says that the transactions "strengthen" its relationships with its customers and "broaden" its "portfolio," improving its offerings for autonomous vehicles. Weber keeps an Outperform rating on the stock.

  • 19

    Oct

WBC Wabco
$150.14

0.95 (0.64%)

06/15/17
PIPR
06/15/17
NO CHANGE
Target $143
PIPR
Overweight
Wabco the only truck stock worth owning, says Piper Jaffray
Piper Jaffray Alexander Potter says Wabco Holdings (WBC) is the only truck stock worth owning and he raised his price target for the shares to $143 from $129. The company's upcoming analyst day should illuminate the point that it will benefit, not be disrupted by, secular trends in the industry, Potter tells investors in a research note. A tech company with autonomous truck ambitions could buy Wabco and then use its "dominant position" in braking/stability control to drive standardization around a suite of self-driving algorithms, the analyst argues. Ignoring a potential takeover, the analyst still believes investors should buy Wabco to benefit from growth themes like automation and connectivity. He keeps an Overweight rating on the shares.
07/21/17
STFL
07/21/17
NO CHANGE
STFL
Wabco price target raised to $150 from $130 at Stifel
After Wabco delivered beat and raise Q2 results, Stifel analyst Michael Baudendistel says the company "is firing on all cylinders." He says that the fact that it received a takeover offer during the quarter shows that others recognize the value of its business. He keeps a Buy rating on the stock.
09/05/17
BUCK
09/05/17
INITIATION
BUCK
Neutral
Wabco initiated with a Neutral at Buckingham
Buckingham analyst Neil Frohnapple started coverage of WABCO with a $142 price target and a Neutral rating. The analyst thinks that the stock's "risk/reward ratio is balanced at this time."
09/19/17
KEYB
09/19/17
NO CHANGE
Target $161
KEYB
Overweight
Wabco price target raised to $161 from $156 at KeyBanc
KeyBanc analyst Jeffrey Hammond raised is price target for Wabco (WBC) to $161 from $156 following its announced full ownership stake in the Meritor (MTOR) WABCO JV. The analyst reiterates an Overweight rating on Wabco's shares.

TODAY'S FREE FLY STORIES

BLUE

bluebird bio

$171.15

3.25 (1.94%)

20:25
12/10/17
12/10
20:25
12/10/17
20:25
Conference/Events
bluebird bio to hold a webcast »

Management provides a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

  • 14

    Dec

DIS

Disney

$104.23

-0.19 (-0.18%)

, GOOG

Alphabet

$1,037.05

6.12 (0.59%)

20:06
12/10/17
12/10
20:06
12/10/17
20:06
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

DIS

Disney

$104.23

-0.19 (-0.18%)

GOOG

Alphabet

$1,037.05

6.12 (0.59%)

GOOGL

Alphabet Class A

$1,049.38

4.81 (0.46%)

DAL

Delta Air Lines

$53.46

0.05 (0.09%)

BRK.A

Berkshire Hathaway

$294,385.33

285.33 (0.10%)

VLKAY

Volkswagen

$40.10

0.6 (1.52%)

PXD

Pioneer Natural

$155.90

1.65 (1.07%)

AMAT

Applied Materials

$51.43

-0.87 (-1.66%)

EPD

Enterprise Products

$24.94

0.25 (1.01%)

ALLY

Ally Financial

$28.65

0.28 (0.99%)

ANTM

Anthem

$224.85

1.21 (0.54%)

USFD

US Foods

$31.00

0.38 (1.24%)

TJX

TJX

$73.88

0.04 (0.05%)

ROST

Ross Stores

$76.89

0.19 (0.25%)

MBI

MBIA

$8.08

-0.01 (-0.12%)

CVS

CVS Health

$73.09

2 (2.81%)

T

AT&T

$36.73

0.56 (1.55%)

DISH

Dish

$48.59

-0.36 (-0.74%)

SNE

Sony

$45.79

0.04 (0.09%)

FOX

21st Century Fox

$32.97

-0.8 (-2.37%)

FOXA

21st Century Fox

$33.30

-0.88 (-2.57%)

TM

Toyota

$124.45

1.06 (0.86%)

SFTBY

SoftBank

$41.62

-0.02 (-0.05%)

GGP

GGP

$23.43

0.03 (0.13%)

BPY

Brookfield Property

$21.61

0.08 (0.37%)

HCA

HCA Healthcare

$84.84

-0.22 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 14

    Dec

  • 14

    Dec

  • 09

    Jan

  • 23

    Jan

  • 07

    Feb

  • 18

    Mar

  • 08

    May

AKTX

Akari Therapeutics

$4.90

-0.14 (-2.78%)

19:25
12/10/17
12/10
19:25
12/10/17
19:25
Conference/Events
Akari Therapeutics to hold an investor and analyst event »

In conjunction with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

BMRN

BioMarin

$81.99

1.09 (1.35%)

, ALXN

Alexion

$114.46

7.68 (7.19%)

19:11
12/10/17
12/10
19:11
12/10/17
19:11
Recommendations
BioMarin, Alexion, Celgene analyst commentary at Piper Jaffray »

Piper Jaffray remains…

BMRN

BioMarin

$81.99

1.09 (1.35%)

ALXN

Alexion

$114.46

7.68 (7.19%)

CELG

Celgene

$106.09

3.36 (3.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

  • 08

    Jan

  • 18

    Jan

  • 28

    Feb

  • 25

    Mar

TWX

Time Warner

$90.71

0.34 (0.38%)

, CMCSA

Comcast

$37.95

0.06 (0.16%)

18:50
12/10/17
12/10
18:50
12/10/17
18:50
Hot Stocks
Box Office Battle: 'Coco' stays number 1 with $18.3M »

Disney (DIS) and…

TWX

Time Warner

$90.71

0.34 (0.38%)

CMCSA

Comcast

$37.95

0.06 (0.16%)

CMCSK

Comcast

SNE

Sony

$45.79

0.04 (0.09%)

FOX

21st Century Fox

$32.97

-0.8 (-2.37%)

FOXA

21st Century Fox

$33.30

-0.88 (-2.57%)

LGF.A

Lionsgate

$31.56

-0.07 (-0.22%)

DIS

Disney

$104.23

-0.19 (-0.18%)

VIAB

Viacom

$29.29

-0.35 (-1.18%)

VIA

Viacom

$34.00

-0.25 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

VLKAY

Volkswagen

$40.10

0.6 (1.52%)

18:38
12/10/17
12/10
18:38
12/10/17
18:38
Periodicals
Volkswagen CEO suggests ending diesel vehicles subsidies, NY Times reports »

Volkswagen CEO said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCA

HCA Healthcare

$84.84

-0.22 (-0.26%)

18:35
12/10/17
12/10
18:35
12/10/17
18:35
Periodicals
Hospital giants in talks to merge, WSJ reports »

Ascension and Providence…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$40.10

0.6 (1.52%)

18:27
12/10/17
12/10
18:27
12/10/17
18:27
Periodicals
Volkswagen executive may ask to serve sentence in Germany, Reuters says »

Volkswagen executive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GGP

GGP

$23.43

0.03 (0.13%)

, BPY

Brookfield Property

$21.61

0.08 (0.37%)

18:21
12/10/17
12/10
18:21
12/10/17
18:21
Periodicals
Mall owner GGP rejects Brookfield Property buyout offer, Reuters reports »

U.S. mall owner GGP (GGP)…

GGP

GGP

$23.43

0.03 (0.13%)

BPY

Brookfield Property

$21.61

0.08 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRC

AtriCure

$17.96

0.01 (0.06%)

18:16
12/10/17
12/10
18:16
12/10/17
18:16
Recommendations
AtriCure analyst commentary at Piper Jaffray »

Piper Jaffray remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

KPTI

Karyopharm

$11.11

0.48 (4.52%)

18:11
12/10/17
12/10
18:11
12/10/17
18:11
Hot Stocks
Karyopharm presents positive phase 1/2 Eltanexor data »

Karyopharm Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KPTI

Karyopharm

$11.11

0.48 (4.52%)

18:09
12/10/17
12/10
18:09
12/10/17
18:09
Hot Stocks
Karyopharm presents positive Selinexor data from STOMP study »

Karyopharm Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGIO

Agios Pharmaceuticals

$60.97

0.14 (0.23%)

18:05
12/10/17
12/10
18:05
12/10/17
18:05
Hot Stocks
Agios Pharmaceuticals presents updated data from DRIVE PK study »

Agios Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

ICL

ICL

$4.03

-0.07 (-1.71%)

18:01
12/10/17
12/10
18:01
12/10/17
18:01
Hot Stocks
ICL completes sale of 50% share of IDE Technologies for $167M »

ICL announced that it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$32.74

0.52 (1.61%)

17:52
12/10/17
12/10
17:52
12/10/17
17:52
Hot Stocks
AstraZeneca Calquence shows potential in chronic lymphocytic leukemia trials »

AstraZeneca and Acerta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZIOP

Ziopharm

$4.43

0.09 (2.07%)

, XON

Intrexon

$13.28

0.16 (1.22%)

17:48
12/10/17
12/10
17:48
12/10/17
17:48
Hot Stocks
Ziopharm announces presentation of data from T-Cell Therapy programs »

Ziopharm Oncology (ZIOP)…

ZIOP

Ziopharm

$4.43

0.09 (2.07%)

XON

Intrexon

$13.28

0.16 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

bluebird bio

$171.15

3.25 (1.94%)

17:45
12/10/17
12/10
17:45
12/10/17
17:45
Hot Stocks
bluebird bio announces results from LentiGlobin study in Severe Sickle Cell »

bluebird bio announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

  • 14

    Dec

BLUE

bluebird bio

$171.15

3.25 (1.94%)

17:37
12/10/17
12/10
17:37
12/10/17
17:37
Hot Stocks
bluebird bio presents new data from clinical studies of LentiGlobin Gene Therapy »

bluebird bio announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

  • 14

    Dec

VSTM

Verastem

$4.33

0.36 (9.07%)

17:35
12/10/17
12/10
17:35
12/10/17
17:35
Hot Stocks
Verastem announces phase 3 DUO study met primary endpoint »

Verastem announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

CELG

Celgene

$106.09

3.36 (3.27%)

, BLUE

bluebird bio

$171.15

3.25 (1.94%)

17:30
12/10/17
12/10
17:30
12/10/17
17:30
Hot Stocks
Celgene, bluebird bio announce updated results from CRB-401 Phase 1 study »

Celgene (CELG) and…

CELG

Celgene

$106.09

3.36 (3.27%)

BLUE

bluebird bio

$171.15

3.25 (1.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 14

    Dec

  • 18

    Jan

  • 25

    Mar

GILD

Gilead

$74.22

1.5 (2.06%)

17:22
12/10/17
12/10
17:22
12/10/17
17:22
Hot Stocks
Kite announces long-term data from pivotal ZUMA-1 study of Yescarta »

Kite, a Gilead company,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

EPZM

Epizyme

$13.25

0.25 (1.92%)

17:18
12/10/17
12/10
17:18
12/10/17
17:18
Hot Stocks
Epizyme presents new biomarker data on Tazemetostat »

Epizyme announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIVV

Bioverativ

$51.47

0.76 (1.50%)

17:16
12/10/17
12/10
17:16
12/10/17
17:16
Hot Stocks
Study shows Bioverativ Eloctate has potential to improve bleed protection »

Bioverativ and Swedish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYRS

Syros Pharmaceuticals

$12.37

-0.505 (-3.92%)

17:04
12/10/17
12/10
17:04
12/10/17
17:04
Hot Stocks
Syros Pharmaceuticals announces new preclinical data on SY-1365 »

Syros Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

SYRS

Syros Pharmaceuticals

$12.37

-0.505 (-3.92%)

17:00
12/10/17
12/10
17:00
12/10/17
17:00
Hot Stocks
Syros Pharmaceuticals announces initial data from phase 2 trial of SY-1425 »

Syros Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.